Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
11,879
datasets available to search
ShareScore release 0.9.0
Dataset results
11,879 results for “participation”
Safety and Pharmacokinetics of Oral Islatravir (MK-8591) Once Monthly in Participants at Low Risk of Human Immunodeficiency Virus 1 (HIV-1) Infection (MK-8591-016)
ClinicalTrials.gov study NCT04003103. IPD Sharing: YES. Countries: 3. Publications: 3.
A Study of Baricitinib (LY3009104) in Participants With Moderate to Severe Atopic Dermatitis
ClinicalTrials.gov study NCT03559270. IPD Sharing: YES. Countries: 3. Publications: 2.
Safety and Immunogenicity of a Mycobacterium Tuberculosis Vaccine M72/AS01E in Participants With Well-controlled HIV
ClinicalTrials.gov study NCT04556981. IPD Sharing: YES. Countries: 1. Publications: 1.
A Study to Assess the Safety and Tolerability of Different Doses of AG019 Administered Alone or in Combination With Teplizumab in Participants With Recent-onset Diagnosed Type 1 Diabetes (T1D)
ClinicalTrials.gov study NCT03751007. IPD Sharing: Not stated. Countries: 2. Publications: 2.
Study to Evaluate the Safety and Efficacy of Lenacapavir (GS-6207) in Combination With an Optimized Background Regimen (OBR) in Heavily Treatment Experienced Participants Living With HIV-1 Infection W
ClinicalTrials.gov study NCT04150068. IPD Sharing: NO. Countries: 11. Publications: 3.
Efficacy Comparison of Dostarlimab Plus Chemotherapy Versus Pembrolizumab Plus Chemotherapy in Participants With Metastatic Non-squamous Non-small Cell Lung Cancer (NSCLC)
ClinicalTrials.gov study NCT04581824. IPD Sharing: YES. Countries: 12. Publications: 3.
A Study of LY2951742 (Galcanezumab) in Participants With Cluster Headache
ClinicalTrials.gov study NCT02797951. IPD Sharing: YES. Countries: 12. Publications: 1.
A Study of LY900014 in Participants With Type 1 Diabetes
ClinicalTrials.gov study NCT03214367. IPD Sharing: YES. Countries: 20. Publications: 4.
Evaluate F901318 (Olorofim) Treatment of Invasive Fungal Infections in Participants Lacking Treatment Options
ClinicalTrials.gov study NCT03583164. IPD Sharing: YES. Countries: 17. Publications: 1.
A Study of the Efficacy and Safety of Frespaciguat (MK-5475) in Participants With Pulmonary Arterial Hypertension (INSIGNIA-PAH: Phase 2/3 Study of an Inhaled sGC Stimulator in PAH) (MK-5475-007)
ClinicalTrials.gov study NCT04732221. IPD Sharing: YES. Countries: 18. Publications: 1.
A Study to Evaluate the Efficacy and Safety of Faricimab in Participants With Neovascular Age-Related Macular Degeneration (TENAYA)
ClinicalTrials.gov study NCT03823287. IPD Sharing: YES. Countries: 15. Publications: 4.
A Study of Niraparib Combined With Bevacizumab Maintenance Treatment in Participants With Advanced Ovarian Cancer Following Response on Front-Line Platinum-Based Chemotherapy
ClinicalTrials.gov study NCT03326193. IPD Sharing: NO. Countries: 1. Publications: 1.
A Study in Participants With Type I Diabetes Mellitus
ClinicalTrials.gov study NCT01454284. IPD Sharing: Not stated. Countries: 20. Publications: 4.
Cardiovascular Safety of Febuxostat and Allopurinol in Participants With Gout and Cardiovascular Comorbidities (CARES)
ClinicalTrials.gov study NCT01101035. IPD Sharing: Not stated. Countries: 2. Publications: 4.
A Study to Evaluate Efficacy and Safety of LCI699 in Participants With Essential Hypertension
ClinicalTrials.gov study NCT00758524. IPD Sharing: Not stated. Countries: 1. Publications: 2.
A Study to Evaluate Safety and Efficacy of Panobinostat in Participants With Primary Myelofibrosis
ClinicalTrials.gov study NCT00931762. IPD Sharing: Not stated. Countries: 1. Publications: 1.
An Extension Protocol for Multiple Sclerosis Patients Who Participated in Genzyme-Sponsored Studies of Alemtuzumab
ClinicalTrials.gov study NCT00930553. IPD Sharing: Not stated. Countries: 23. Publications: 18.
CoolCap Followup Study-Coordination of Participating Centers
ClinicalTrials.gov study NCT00581581. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Safety and Tolerability of Pirfenidone in Participants With Systemic Sclerosis-Related Interstitial Lung Disease (SSc-ILD) (LOTUSS)
ClinicalTrials.gov study NCT01933334. IPD Sharing: Not stated. Countries: 3. Publications: 2.
Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Participants With Gastric Cancer and Adenocarcinoma
ClinicalTrials.gov study NCT00917384. IPD Sharing: YES. Countries: 30. Publications: 3.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.